Georgetown University/Lombardi Cancer Center Dept.of Lombardi Cancer Ctr (2 is a clinical research site located in Washington D.C., District of Columbia, United States 20007-2197.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Georgetown University/Lombardi Cancer Center Dept.of Lombardi Cancer Ctr (2 has participated in 1 clinical trials.
Therapeutic areas: Renal Cell Carcinoma.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Georgetown University/Lombardi Cancer Center Dept.of Lombardi Cancer Ctr (2 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Georgetown University/Lombardi Cancer Center Dept.of Lombardi Cancer Ctr (2 has 1 clinical trials on record. Their work covers Renal Cell Carcinoma.
Georgetown University/Lombardi Cancer Center Dept.of Lombardi Cancer Ctr (2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.